Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline

BACKGROUND: The live attenuated 17DD Yellow Fever vaccine is one of the most successful prophylactic interventions for controlling disease expansion ever designed and utilized in larger scale. However, increase on worldwide vaccine demands and manufacturing restrictions urge for more detailed dose s...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMC Infect Dis
المؤلفون الرئيسيون: Campi-Azevedo, Ana Carolina, de Almeida Estevam, Paula, Coelho-dos-Reis, Jordana Grazziela, Peruhype-Magalhães, Vanessa, Villela-Rezende, Gabriela, Quaresma, Patrícia Flávia, Maia, Maria de Lourdes Sousa, Farias, Roberto Henrique Guedes, Camacho, Luiz Antonio Bastos, Freire, Marcos da Silva, Galler, Ricardo, Yamamura, Anna Maya Yoshida, Almeida, Luiz Fernando Carvalho, Lima, Sheila Maria Barbosa, Nogueira, Rita Maria Ribeiro, Silva Sá, Gloria Regina, Hokama, Darcy Akemi, de Carvalho, Ricardo, Freire, Ricardo Aguiar Villanova, Filho, Edson Pereira, Leal, Maria da Luz Fernandes, Homma, Akira, Teixeira-Carvalho, Andréa, Martins, Reinaldo Menezes, Martins-Filho, Olindo Assis
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2014
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223624/
https://ncbi.nlm.nih.gov/pubmed/25022840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-391
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة